Polaryx Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Polaryx Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- PLYX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002075320
Board of directors
-
Alex Keun Mo Yang · Director · Chief Executive OfficerSince 2026
-
Charles S. Ryan · DirectorSince 2026
-
G. Michael Landis · Director · Chief Financial OfficerSince 2026
-
Iii Francis A. Braun · DirectorSince 2026
-
Mitchel Berger · DirectorSince 2026
Chief executives
Alex Keun Mo Yang
· Chief Executive Officer
Since January 2026
Director election results
Annual meeting of September 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
100.0%
-
100.0%
Board connections
1 of this board's directors also sit on 3 other boards.
- via Iii Francis A. Braun
- via Iii Francis A. Braun
- via Iii Francis A. Braun
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $368,003
- 2 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 27, 2026 | Mstone Partners Healthcare Ltd Director, 10% owner | Open-market purchase | +88,453 | $4.07 | $360,004 |
| Feb 18, 2026 | G. Michael Landis Director, Officer (Chief Financial Officer) | Open-market purchase | +2,867 | $2.79 | $7,999 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.